Growth Metrics

Invivyd (IVVD) Operating Leases (2022 - 2025)

Invivyd posted quarterly Operating Leases of $1.2 million for Q4 2025, down 31.07% year-on-year from $1.7 million in Q4 2024, and down 24.72% on a QoQ basis from $1.6 million in Q3 2025.

Invivyd (IVVD) has 4 years of Operating Leases data on file, last reported at $1.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Operating Leases fell 31.07% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2025 stood at $1.2 million (down 31.07% YoY), and the FY2025 full-year result was $1.2 million, down 31.07% from the prior year.
  • Operating Leases for Q4 2025 stood at $1.2 million, down from $1.6 million in the prior quarter.
  • Across five years, Operating Leases topped out at $1.9 million in Q2 2022 and bottomed at $100000.0 in Q1 2022.
  • The 4-year median for Operating Leases is $1.2 million (2022), against an average of $1.1 million.
  • The widest annual swing landed in 2024, when Operating Leases tumbled 76.38%; it then surged 627.85% in 2025.
  • A 4-year view of Operating Leases shows it stood at $837000.0 in 2022, then jumped by 106.81% to $1.7 million in 2023, then advanced by 0.58% to $1.7 million in 2024, then sank by 31.07% to $1.2 million in 2025.
  • The last three Operating Leases figures came in at $1.2 million (Q4 2025), $1.6 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Invivyd 208.38 Mn -18.31 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.20 Mn
Sep 30, 2025 1.59 Mn
Jun 30, 2025 1.90 Mn
Mar 31, 2025 425,000.00
Dec 31, 2024 1.74 Mn
Sep 30, 2024 219,000.00
Mar 31, 2024 435,000.00
Dec 31, 2023 1.73 Mn
Sep 30, 2023 927,000.00
Jun 30, 2023 1.30 Mn
Mar 31, 2023 432,000.00
Dec 31, 2022 837,000.00
Sep 30, 2022 1.18 Mn
Jun 30, 2022 1.90 Mn
Mar 31, 2022 100,000.00